Page 276 - Tata_Chemicals_yearly-reports-2020-2021
P. 276

Integrated Annual Report 2020-21



               for striking off its name from the register of companies w.e.f March 29, 2021. Accordingly, RCEL has ceased to be a subsidiary of the
               Group effective the said date.
           (iv)   The Hon’ble National Company Law Tribunal (NCLT), Bengaluru Bench and the NCLT, Mumbai Bench have approved the Scheme
               of Merger by Absorption of  Metahelix Life Sciences Limited (WOS of Rallis) with Rallis India Limited (‘Scheme’) from the Appointed
               Date of April 1, 2019. The Effective Date of the Scheme is February 1, 2020. Accordingly, Metahelix has ceased to be a subsidiary of
               the Company with effect from February 1, 2020. There is no impact of this transaction on the Consolidated Financial Statements.
           (v)    The NCLT, Mumbai Bench also approved the Scheme of Amalgamation of Zero Waste Agro Organics Limited (WOS of Rallis) with
               Rallis India Limited (‘Scheme’) on February 22, 2020 from the Appointed Date of April 1, 2017. The Effective Date of the Scheme is July
               9, 2020. Accordingly, Zero Waste has ceased to be a subsidiary of the Company with effect from July 9, 2020. There is no impact of
               this transaction on the Consolidated Financial Statements.
           (vi)   The Hon'ble National Company Law Tribunal ('NCLT'), Mumbai Bench on April 23, 2020 approved the Scheme of  Merger by Absorption
               of Bio Energy Venture-1 (Mauritius) Pvt. Ltd. ('Bio'), a wholly owned subsidiary of the Company, with the Company ('Scheme'), with an
               Appointed Date of April 1 2019. The Registrar of Companies at Mauritius  removed the name of Bio from the register of companies
               w.e.f. June 1, 2020 and accordingly, Bio has ceased to be a subsidiary of the Company with effect from June 1, 2020.   Consequent to
               this, TCIPL has become a direct wholly owned subsidiary of the Company with effect from that date. There is no impact of the merger
               in the Consolidated Financial Statements.
           (vii)   During the year, PT Metahelix Life Sciences Indonesia, a subsidiary of Rallis, received approval for the cancellation of its Company
               Registration Number and revocation of its business license w.e.f March 19, 2021. Further, an application for cancellation of its Tax
               Identification Number has been made and the approval for the same is awaited.

           39.  Leases
                                                                                                      ` in crore
                                                                                      Year ended   Year ended
                                                                                   March 31, 2021 March 31, 2020
           Maturity analysis – contractual undiscounted cash flows
           Less than one year                                                              100.45       110.06
           One to five years                                                               142.31       184.71
           More than five years                                                             82.51        53.41
           Total undiscounted lease liabilities                                           325.27       348.18
           Discounted Cash flows
           Current                                                                          91.98        87.42
           Non-Current                                                                     188.60       188.00
           Lease liabilities                                                              280.58       275.42
           Expenses relating to short-term leases and low value assets have been disclosed under rent in note 33(e).
           The incremental borrowing rate of 1.20% per annum to 13.00% per annum (2020: 1.90% per annum to 13.00% per annum) has been
           applied to lease liabilities recognised in the Consolidated Balance Sheet.

           40.  Employee benefits obligations
           (a)  In respect of the Company and domestic subsidiaries
               The Company and its domestic subsidiaries make contributions towards provident fund, in substance a defined benefit retirement
               plan and towards pension and superannuation funds which are defined contribution retirement plans for qualifying employees. The
               provident fund is administered by the Trustees of the Provident Fund and the superannuation fund is administered by the Trustees
               of the Superannuation Fund. The Company and its domestic subsidiaries are liable to pay to the provident fund to the extent of the
               amount contributed and any shortfall in the fund assets based on Government specified minimum rates of return relating to current
               services. Such contribution and shortfall if any, are recognised as an expense in the year in which these are incurred.

               On account of the above contribution plans, a sum of ` 15.58 crore (2020: ` 14.78 crore) has been charged to the Consolidated
               Statement of Profit and Loss.




           274
   271   272   273   274   275   276   277   278   279   280   281